In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.
Mergers and acquisitions in the mobility sector
In this article published in FleetPoint, CRA’s Enrique Glotzer and Meera Kotak highlight trends in the electric vehicles sector as they pertain to mergers and...